{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:10:53Z","timestamp":1790626253036,"version":"4.1.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>The misuse of Pregabalin has been the subject of growing concern for several years. The effects sought are multiple and it is rarely taken as a single drug. It is most frequently used together with opioids, which may increase the risk of fatal overdose. In response to this emerging phenomenon, we seek to better understand the situation of misuse in Belgium and identify the people involved in it.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodology<\/jats:title>\n                <jats:p>A qualitative study using semi-structured interviews with 20 participants who misuse Pregabalin was conducted throughout the French-speaking region of Belgium between August 2021 and January 2022. Recruitment mostly took place in addictions centers, shelters for migrants and homeless persons and primary care centers. We then conducted a thematic analysis with the help of Nvivo software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A profile emerged, of young male users, immigrants, mainly first generation immigrants coming from North Africa. They had in common a challenging or even traumatic migration pathway and precarious living conditions in Belgian territory. Most of them had no stable income. They saw Pregabalin as enabling them to cope with their daily situation. All had psychiatric and\/or somatic comorbidities for which they had apparently not recieved adequate medical care. This seemed to lead many of them to use Pregabalin as self-medication, for anxiety-depressive disorders and chronic pain, and it was sometimes initiated in their home country. Pregabalin was never used alone.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study has highlighted a rare and insufficient documented profile of Pregabalin misuse: self-medication among a group of first generation immigrants, most of whom have no previous history of opioid-related disorders. Measures should be taken to improve access to health and social care for this population, considering all their biopsychosocial vulnerabilities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-023-16051-6","type":"journal-article","created":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:02:14Z","timestamp":1689152534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Misuse of Pregabalin: a qualitative study from a patient\u2019s perspective"],"prefix":"10.1186","volume":"23","author":[{"given":"Louise","family":"Servais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Huberland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lou","family":"Richelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,12]]},"reference":[{"key":"16051_CR1","unstructured":"Folia. CBIP. [Cited 19 Apr 2022]. Available from: https:\/\/www.cbip.be\/fr\/articles\/query?number=F47F02B."},{"key":"16051_CR2","unstructured":"Folia. CBIP. [Cited 19 Apr 2022]. Available from: https:\/\/www.cbip.be\/fr\/articles\/query?number=F45F02B."},{"issue":"1","key":"16051_CR3","doi-asserted-by":"publisher","first-page":"12556","DOI":"10.1007\/s40265-020-01432-7","volume":"81","author":"KE Evoy","year":"2021","unstructured":"Evoy KE, Sadrameli S, Contreras J, Covvey JR, Peckham AM, Morrison MD. Abuse and Misuse of Pregabalin and Gabapentin: A Systematic Review Update. Drugs. 2021;81(1):12556.","journal-title":"Drugs"},{"issue":"7","key":"16051_CR4","doi-asserted-by":"publisher","first-page":"64754","DOI":"10.1007\/s40263-016-0359-y","volume":"30","author":"S Chiappini","year":"2016","unstructured":"Chiappini S, Schifano F. A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency\u2019s \u201cSuspected Adverse Drug Reactions\u201d Database. CNS Drugs. 2016;30(7):64754.","journal-title":"CNS Drugs"},{"issue":"8","key":"16051_CR5","first-page":"9538","volume":"15","author":"KE Evoy","year":"2019","unstructured":"Evoy KE, Covvey JR, Peckham AM, Ochs L, Hultgren KE. Reports of gabapentin and pregabalin abuse, misuse, dependence, or overdose: An analysis of the Food And Drug Administration Adverse Events Reporting System (FAERS). Res Soc Adm Pham. 2019;15(8):9538.","journal-title":"Res Soc Adm Pham"},{"key":"16051_CR6","doi-asserted-by":"crossref","unstructured":"Molero Y, Larsson H, D'Onofrio BM, Sharp DJ, Fazel S. Associations between gabapentinoids and suicidal behaviour, unintentional overdoses, injuries, road traffic incidents, and violent crime: population based cohort study in Sweden. BMJ. 2019;365:l2147.","DOI":"10.1136\/bmj.l2147"},{"issue":"9","key":"16051_CR7","doi-asserted-by":"publisher","first-page":"15809","DOI":"10.1111\/add.13843","volume":"112","author":"A Lyndon","year":"2017","unstructured":"Lyndon A, Audrey S, Wells C, Burnell ES, Ingle S, Hill R, et al. Risk to heroin users of poly-drug use of pregabalin or gabapentin. Addiction. 2017;112(9):15809.","journal-title":"Addiction"},{"issue":"5","key":"16051_CR8","doi-asserted-by":"publisher","first-page":"65960","DOI":"10.1111\/cns.13115","volume":"25","author":"F Schifano","year":"2019","unstructured":"Schifano F, Chiappini S. Pregabalin: A range of misuse-related unanswered questions. CNS Neurosci Ther. 2019;25(5):65960.","journal-title":"CNS Neurosci Ther"},{"issue":"12","key":"16051_CR9","doi-asserted-by":"publisher","first-page":"1185215","DOI":"10.1016\/j.euroneuro.2017.08.430","volume":"27","author":"U Bonnet","year":"2017","unstructured":"Bonnet U, Scherbaum N. How addictive are gabapentin and pregabalin? A systematic review. Eur Neuropsychopharmacol. 2017;27(12):1185215.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"12","key":"16051_CR10","doi-asserted-by":"publisher","first-page":"123554","DOI":"10.1007\/s40264-020-00985-6","volume":"43","author":"S H\u00e4gg","year":"2020","unstructured":"H\u00e4gg S, J\u00f6nsson AK, Ahlner J. Current Evidence on Abuse and Misuse of Gabapentinoids. Drug Saf. 2020;43(12):123554.","journal-title":"Drug Saf"},{"issue":"3","key":"16051_CR11","doi-asserted-by":"publisher","first-page":"23846","DOI":"10.1080\/02791072.2020.1861392","volume":"53","author":"E Peles","year":"2021","unstructured":"Peles E, Sason A, Schreiber S, Adelson M. Pregabalin Misuse: Motives, Pattern, and Knowledge about Its Risks among Patients in Methadone Maintenance Treatment. J Psychoactive Drugs. 2021;53(3):23846.","journal-title":"J Psychoactive Drugs"},{"issue":"6","key":"16051_CR12","doi-asserted-by":"publisher","first-page":"12609","DOI":"10.1111\/bcp.13892","volume":"85","author":"D Driot","year":"2019","unstructured":"Driot D, Jouanjus E, Oustric S, Dupouy J, Lapeyre-Mestre M. Patterns of gabapentin and pregabalin use and misuse: Results of a population-based cohort study in France. Br J Clin Pharmacol. 2019;85(6):12609.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"16051_CR13","doi-asserted-by":"publisher","first-page":"197204","DOI":"10.1007\/s00228-013-1594-5","volume":"70","author":"R Bod\u00e9n","year":"2014","unstructured":"Bod\u00e9n R, Wettermark B, Brandt L, Kieler H. Factors associated with pregabalin dispensing at higher than the approved maximum dose. Eur J Clin Pharmacol. 2014;70(2):197204.","journal-title":"Eur J Clin Pharmacol"},{"key":"16051_CR14","volume-title":"Tableau de bord de l'usage de drogues et ses cons\u00e9quences socio sanitaires en R\u00e9gion de Bruxelles Capitale","author":"C St\u00e9venot","year":"2021","unstructured":"St\u00e9venot C, Hogge M. Tableau de bord de l\u2019usage de drogues et ses cons\u00e9quences socio sanitaires en R\u00e9gion de Bruxelles Capitale. Brussels: Eurotox asbl; 2021."},{"key":"16051_CR15","volume-title":"Tableau de bord de l'usage de drogues et ses cons\u00e9quences socio sanitaires en Wallonie","author":"C St\u00e9venot","year":"2021","unstructured":"St\u00e9venot C, Hogge M. Tableau de bord de l\u2019usage de drogues et ses cons\u00e9quences socio sanitaires en Wallonie. Brussels: Eurotox asbl; 2021."},{"key":"16051_CR16","volume-title":"Pr\u00e9gabaline - Etat des lieux en R\u00e9gion de Bruxelles-Capitale, Dossier d'information","author":"ASBL Transit","year":"2021","unstructured":"Transit ASBL. Pr\u00e9gabaline - Etat des lieux en R\u00e9gion de Bruxelles-Capitale, Dossier d\u2019information. 2021."},{"issue":"2","key":"16051_CR17","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1071\/HE09133","volume":"20","author":"P Liamputtong","year":"2009","unstructured":"Liamputtong P. Qualitative data analysis: conceptual and practical considerations. Health Promot J Aust. 2009;20(2):1339.","journal-title":"Health Promot J Aust"},{"issue":"11","key":"16051_CR18","first-page":"102730","volume":"59","author":"L Dufayet","year":"2021","unstructured":"Dufayet L, Care W, Deheul S, Laborde-Casterot H, Nisse P, Langrand J, et al. Increase in pregabalin recreational use in adolescents in France. Null. 2021;59(11):102730.","journal-title":"Null."},{"key":"16051_CR19","volume-title":"Ph\u00e9nom\u00e8nes \u00e9mergents li\u00e9s aux drogues en 2020, Toulouse site, Observatoire fran\u00e7ais des drogues et des toxicomanies","author":"A Roquefort","year":"2021","unstructured":"Roquefort A, Suderie G, Albisson A. Ph\u00e9nom\u00e8nes \u00e9mergents li\u00e9s aux drogues en 2020, Toulouse site, Observatoire fran\u00e7ais des drogues et des toxicomanies. 2021."},{"key":"16051_CR20","volume-title":"Usagers, march\u00e9s et substances : \u00e9volutions r\u00e9centes (2018\u20132019), Observatoire fran\u00e7ais des drogues et des toxicomanies","author":"C G\u00e9rome","year":"2019","unstructured":"G\u00e9rome C, Cadet-Ta\u00efrou A, Gandilhon M, Milhet M, Detrez V, Martinez M. Usagers, march\u00e9s et substances\u202f: \u00e9volutions r\u00e9centes (2018\u20132019), Observatoire fran\u00e7ais des drogues et des toxicomanies. 2019."},{"key":"16051_CR21","doi-asserted-by":"publisher","unstructured":"Tambon M, Pont\u00e9 C, Jouanjus E, Fouilh\u00e9 N, Micallef J, Lapeyre-Mestre M, et al. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance. Frontiers in Psychiatry. 2021 [Cited 19 Apr 2022];12. Available from: https:\/\/doi.org\/10.3389\/fpsyt.2021.639780.","DOI":"10.3389\/fpsyt.2021.639780"},{"key":"16051_CR22","doi-asserted-by":"crossref","unstructured":"Chappuy, M., Nourredine, M., Clerc, B., Fahmi, M., Misslin, P., Berthier, M., Rolland, B. (2021). Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016\u20141Q2021. Fundamental & Clinical Pharmacology.","DOI":"10.1111\/fcp.12726"},{"key":"16051_CR23","volume-title":"A RISING TIDE: Trends in production, trafficking and consumption of drugs in North Africa Global Initiative Against Transnational Organized Crime","author":"M Herbert","year":"2020","unstructured":"Herbert M, Gallien M. A RISING TIDE: Trends in production, trafficking and consumption of drugs in North Africa Global Initiative Against Transnational Organized Crime. 2020."},{"issue":"3","key":"16051_CR24","doi-asserted-by":"publisher","first-page":"64254","DOI":"10.1007\/s11469-017-9813-4","volume":"16","author":"A Al-Husseini","year":"2018","unstructured":"Al-Husseini A, Wazaify M, Van Hout MC. Pregabalin Misuse and Abuse in Jordan: a Qualitative Study of User Experiences. Int J Ment Health Addict. 2018;16(3):64254.","journal-title":"Int J Ment Health Addict."},{"key":"16051_CR25","doi-asserted-by":"publisher","first-page":"5068","DOI":"10.1016\/j.jad.2019.11.165","volume":"264","author":"WK Hou","year":"2020","unstructured":"Hou WK, Liu H, Liang L, Ho J, Kim H, Seong E, et al. Everyday life experiences and mental health among conflict-affected forced migrants: A meta-analysis. J Affect Disord. 2020;264:5068.","journal-title":"J Affect Disord"},{"issue":"7","key":"16051_CR26","doi-asserted-by":"publisher","first-page":"e0159134","DOI":"10.1371\/journal.pone.0159134","volume":"11","author":"D Horyniak","year":"2016","unstructured":"Horyniak D, Melo JS, Farrell RM, Ojeda VD, Strathdee SA. Epidemiology of Substance Use among Forced Migrants: A Global Systematic Review. PLoS ONE. 2016;11(7):e0159134.","journal-title":"PLoS ONE"},{"key":"16051_CR27","unstructured":"De Kock et al, Mapping & enhancing substance use treatment for migrants and ethnic minorities. Federal Research Programme on Drugs MATREMI Final Report. Brussels: Belgian Science Policy Office 2020 - 267 ."},{"key":"16051_CR28","unstructured":"World Health Organization, Regional Office for Europe. Report on the health of refugees and migrants in the WHO European Region: no public health without refugee and migrant health.\u00a0Copenhagen \u00d8: World Health Organization, Regional Office for Europe; 2018."},{"issue":"4","key":"16051_CR29","doi-asserted-by":"publisher","first-page":"e42035","DOI":"10.1016\/S2214-109X(18)30560-6","volume":"7","author":"SP Ju\u00e1rez","year":"2019","unstructured":"Ju\u00e1rez SP, Honkaniemi H, Dunlavy AC, Aldridge RW, Barreto ML, Katikireddi SV, et al. Effects of non-health-targeted policies on migrant health: a systematic review and meta-analysis. Lancet Global Health. 2019;7(4):e42035.","journal-title":"Lancet Global Health"},{"issue":"7","key":"16051_CR30","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1111\/add.15800","volume":"117","author":"T DeFries","year":"2022","unstructured":"DeFries T, Kelley J, Martin M, Kimball SL. Immigration status matters: the intersectional risk of immigration vulnerability and substance use disorder. Addiction. 2022;117(7):1827\u20139.","journal-title":"Addiction"},{"key":"16051_CR31","doi-asserted-by":"publisher","unstructured":"van Dorp, Melissa; Boon, Albert; Spijkerman, Renske; Los, Leontien (2020). Substance use prevalence rates among migrant and native adolescents in Europe: A systematic review. Drug and Alcohol Review, (), dar.13154 https:\/\/doi.org\/10.1111\/dar.13154.","DOI":"10.1111\/dar.13154"},{"key":"16051_CR32","unstructured":"ebm0111b. Ebpracticenet. [Cited 19 Apr 2022]. Available from: https:\/\/ebpnet.be\/fr\/ebsources\/1209."},{"key":"16051_CR33","first-page":"6","volume":"351","author":"T Orban","year":"2018","unstructured":"Orban T. La d\u00e9pression chez l\u2019adulte. La Revue de la M\u00e9decine G\u00e9n\u00e9rale. 2018;351:6\u201311.","journal-title":"La Revue de la M\u00e9decine G\u00e9n\u00e9rale"},{"key":"16051_CR34","unstructured":"ebm00703. Ebpracticenet. [Cited 19 Apr 2022]. Available from: https:\/\/ebpnet.be\/fr\/ebsources\/817."},{"issue":"10","key":"16051_CR35","doi-asserted-by":"publisher","first-page":"1699700","DOI":"10.1111\/add.13408","volume":"111","author":"C Stannard","year":"2016","unstructured":"Stannard C. Misuse of gabapentin and pregabalin: a marker for a more serious malaise? Addiction. 2016;111(10):1699700.","journal-title":"Addiction"},{"key":"16051_CR36","volume-title":"Which health care for illegal residents? \u2013Synthesis Health. Services Research (HSR)","author":"D Roberfroid","year":"2015","unstructured":"Roberfroid D, Dauvrin M, Keygnaert I, Desomer A, Kerstens B, Camberlin C, Gysen J, Lorant V, Derluyn I. Which health care for illegal residents? \u2013Synthesis Health. Services Research (HSR). Brussels: Federal Expertise Centre for Health Care (KCE); 2015."},{"issue":"6","key":"16051_CR37","doi-asserted-by":"publisher","first-page":"e0252651","DOI":"10.1371\/journal.pone.0252651","volume":"16","author":"F Pega","year":"2021","unstructured":"Pega F, Govindaraj S, Tran NT. Health service use and health outcomes among international migrant workers compared with non-migrant workers: A systematic review and meta-analysis. PLoS ONE. 2021;16(6):e0252651.","journal-title":"PLoS ONE"},{"issue":"9","key":"16051_CR38","doi-asserted-by":"publisher","first-page":"83554","DOI":"10.1007\/s40263-014-0192-0","volume":"28","author":"JE Frampton","year":"2014","unstructured":"Frampton JE. Pregabalin: A Review of its Use in Adults with Generalized Anxiety Disorder. CNS Drugs. 2014;28(9):83554.","journal-title":"CNS Drugs"},{"key":"16051_CR39","unstructured":"Declercq T., Callens J, Cloetens H., De Lepeleire J., Habraken H., van den Ameele H., Good Practice Recommendation: Depression in adults. SSMG; 2017."},{"issue":"6","key":"16051_CR40","doi-asserted-by":"publisher","first-page":"132046","DOI":"10.1007\/s10903-020-01055-w","volume":"22","author":"D Sambucini","year":"2020","unstructured":"Sambucini D, Aceto P, Begotaraj E, Lai C. Efficacy of Psychological Interventions on Depression Anxiety and Somatization in Migrants: A Meta-analysis. J Immigr Minor Health. 2020;22(6):132046.","journal-title":"J Immigr Minor Health"},{"issue":"4","key":"16051_CR41","doi-asserted-by":"publisher","first-page":"37688","DOI":"10.1017\/S2045796019000027","volume":"28","author":"G Turrini","year":"2019","unstructured":"Turrini G, Purgato M, Acarturk C, Anttila M, Au T, Ballette F, et al. Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis. Epidemiol Psychiatr Sci. 2019;28(4):37688.","journal-title":"Epidemiol Psychiatr Sci."},{"key":"16051_CR42","unstructured":"ebm0117b. Ebpracticenet. [Cited 19 Apr 2022]. Available from: https:\/\/ebpnet.be\/fr\/ebsources\/1239."},{"issue":"5","key":"16051_CR43","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.pec.2021.08.021","volume":"105","author":"A Altun","year":"2022","unstructured":"Altun A, Brown H, Sturgiss L, Russell G. Evaluating chronic pain interventions in recent refugees and immigrant populations: a systematic review. Patient Educ Couns. 2022;105(5):1152\u201369.","journal-title":"Patient Educ Couns"},{"issue":"11","key":"16051_CR44","doi-asserted-by":"publisher","first-page":"e012008","DOI":"10.1136\/bmjopen-2016-012008","volume":"6","author":"LP H\u00f6lzel","year":"2016","unstructured":"H\u00f6lzel LP, Ries Z, Kriston L, Dirmaier J, Zill JM, Rummel-Kluge C, et al. Effects of culture-sensitive adaptation of patient information material on usefulness in migrants: a multicentre, blinded randomised controlled trial. BMJ Open. 2016;6(11):e012008.","journal-title":"BMJ Open"},{"issue":"3","key":"16051_CR45","doi-asserted-by":"publisher","first-page":"27280","DOI":"10.3109\/09638288.2016.1140832","volume":"39","author":"D Maki","year":"2017","unstructured":"Maki D, Rajab E, Watson PJ, Critchley DJ. Translation, cross-cultural adaptation and psychometric properties of the Back Beliefs Questionnaire in Modern Standard Arabic. Disab Rehabil. 2017;39(3):27280.","journal-title":"Disab Rehabil"},{"issue":"10","key":"16051_CR46","doi-asserted-by":"publisher","first-page":"e053678","DOI":"10.1136\/bmjopen-2021-053678","volume":"11","author":"K Rustage","year":"2021","unstructured":"Rustage K, Crawshaw A, Majeed-Hajaj S, Deal A, Nellums L, Ciftci Y, et al. Participatory approaches in the development of health interventions for migrants: a systematic review. BMJ Open. 2021;11(10):e053678.","journal-title":"BMJ Open"},{"key":"16051_CR47","doi-asserted-by":"publisher","first-page":"96","DOI":"10.30637\/2022.22-078","volume":"44","author":"L Richelle","year":"2023","unstructured":"Richelle L, Hogge M. Pregabalin misuse in French speaking Belgium: quantitative surveys. Rev Med Brux. 2023;44:96\u2013105.","journal-title":"Rev Med Brux"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-023-16051-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-023-16051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T09:03:04Z","timestamp":1689152584000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-023-16051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,12]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["16051"],"URL":"https:\/\/doi.org\/10.1186\/s12889-023-16051-6","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,12]]},"assertion":[{"value":"21 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Erasme \u2013 ULB ethics committe approved the study the 07\/14\/2021 (Reference number: P2021\/303 \/ CCB B4062021000156). The study has been performed in accordance with the relevant guidelines and regulations. Oral and written informed consent was obtained from each participant.A Consent form was signed by the participants before the interviews.A Consent from the IPPJ director was also obtained for minor patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1339"}}